Dr. Amesh Adalja: The benefits of the Johnson & Johnson vaccine far outweigh the risk
05:19Dr. Amesh Adalja, a senior scholar at John Hopkins, joins MSNBC’s Craig Melvin to discuss growing vaccine hesitancy following the Johnson and Johnson vaccine pause.
